Should You Invest in Marijuana Stocks & ETFs Now?

This article was originally published on this site

  • (1:20) – What Is Pushing Stocks To All Time Highs?
  • (10:35) – Can Investors Expect Federal Legalization Anytime Soon?
  • (17:30) – Reddit Frenzy On The Stock Market: What To Expect From The Volatility
  • (22:20) – Amplify Seymour Cannabis ETF: CNBS
  • (28:30) – Episode Roundup: Podcast@Zacks.com

 

In this episode of ETF Spotlight, I speak with Tim Seymour, founder & CIO of Seymour Asset Management and co-host of CNBC’s Fast Money, about cannabis investing and the Amplify Seymour Cannabis ETF CNBS, which is the best performing marijuana ETF over the past year.

Load Error

Cannabis stocks & ETFs are soaring this year, thanks mainly to favorable policy outlook and improving industry fundamentals. Last week, pot stocks saw a lot of interest from traders on Reddit’s WallStreetBets forum.

Investors are now hoping for a more rapid path to full federal legalization with the Democratic majority in both chambers of Congress. Fifteen states and the District of Columbia allow marijuana’s recreational use now and more states are expected to legalize the drug in the aftermath of the pandemic.

We have also seen a pickup in deal making in the space. Jazz Pharmaceuticals JAZZ is buying GW Pharma GWPH for about $7 Billion, while Aphria APHA and Tilray TLRY are merging to create the biggest global cannabis company.

CNBS has gained more than 180% over the past year, significantly outperforming other marijuana ETFs like AdvisorShares Pure Cannabis ETF YOLO, The Cannabis ETF THCX, Cambria Cannabis ETF TOKE, Global X Cannabis ETF POTX, and ETFMG Alternative Harvest ETF MJ, which have gained between 50% and 150%.

Top holdings in CNBS include GW Pharma, Canopy Growth CGC and Village Farms VFF. Tune into the podcast to learn more.

Make sure to be on the lookout for the next edition of ETF Spotlight and also make sure to subscribe! If you have any comments or questions, please email podcast@zacks.com.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>

Continue Reading